Hai cercato la traduzione di insulin resistance supplements da Spagnolo a Inglese

diabetes, insulin resistance and sugars.
diabetes, insulin resistance and sugars.

later, srebp-1c was identified as a candidate gene in the regulation of human insulin resistance.
later, srebp-1c was identified as a candidate gene in the regulation of human insulin resistance.

two missense mutations in exons coding the aminoterminal transcriptional activating domain of srebp-1c were found in individuals displaying severe insulin resistance.
two missense mutations in exons coding the aminoterminal transcriptional activating domain of srebp-1c were found in individuals displaying severe insulin resistance.

in mice models, overexpression of srebp-1c led to fatty livers, hypertriglyceridemia, severe insulin resistance and finally type 2 diabetes mellitus.
in mice models, overexpression of srebp-1c led to fatty livers, hypertriglyceridemia, severe insulin resistance and finally type 2 diabetes mellitus.

=== oms ===los criterios de la organización mundial de la salud (1999) requieren la presencia de diabetes mellitus, tolerancia anormal a la glucosa, glucemia de ayuno anormal o resistencia a la insulina, mÁs dos de los siguientes:* presión arterial ≥ 140/90 mmhg* dislipidemia: triglicéridos (tg): ≥ 1.695 mmol/l y/o colesterol hdl (hdl-c) ≤ 0.9 mmol/l (en hombres), ≤ 1.0 mmol/l (en mujeres)* obesidad central: relación cintura/cadera > 0.90 (en hombres), > 0.85 (en mujeres), y/o índice de masa corporal (imc) > 30 kg/m2* microalbuminuria: excreción urinaria de albúmina ≥ 20 mg/min o relación albúmina/creatinina en orina ≥ 30 mg/g=== egir ===la european group for the study of insulin resistance (grupo europeo para el estudio de la resistencia a la insulina-1999) requiere la presencia de la resistencia a la insulina, que la define como un incremento del 25% de los valores de insulina en ayunas entre los individuos no-diabéticos, mÁs dos o más de los siguiente:* obesidad central: diámetro de cintura ≥ 94 cm (en hombres), ≥ 80 cm (en mujeres)* dislipidemia: tg ≥ 2.0 mmol/l y/o hdl-c 102 cm.
# if bmi is >30 kg/m², central obesity can be assumed and waist circumference does not need to be measured===who===the world health organization 1999 criteria require the presence of any one of diabetes mellitus, impaired glucose tolerance, impaired fasting glucose or insulin resistance, and two of the following:* blood pressure: ≥ 140/90 mmhg* dyslipidemia: triglycerides (tg): ≥ 1.695 mmol/l and high-density lipoprotein cholesterol (hdl-c) ≤ 0.9 mmol/l (male), ≤ 1.0 mmol/l (female)* central obesity: waist:hip ratio > 0.90 (male); > 0.85 (female), or body mass index > 30 kg/m2* microalbuminuria: urinary albumin excretion ratio ≥ 20 µg/min or albumin:creatinine ratio ≥ 30 mg/g===egir===the european group for the study of insulin resistance (1999) requires insulin resistance defined as the top 25% of the fasting insulin values among nondiabetic individuals and two or more of the following:* central obesity: waist circumference ≥ 94 cm or 37 inches (male), ≥ 80 cm or 31.5 inches (female)* dyslipidemia: tg ≥ 2.0 mmol/l and/or hdl-c < 1.0 mmol/l or treated for dyslipidemia* hypertension: blood pressure ≥ 140/90 mmhg or antihypertensive medication* fasting plasma glucose ≥ 6.1 mmol/l===ncep===the us national cholesterol education program adult treatment panel iii (2001) requires at least three of the following:* central obesity: waist circumference ≥ 102 cm or 40 inches (male), ≥ 88 cm or 35 inches(female)* dyslipidemia: tg ≥ 1.7 mmol/l (150 mg/dl)* dyslipidemia: hdl-c < 40 mg/dl (male), < 50 mg/dl (female)* blood pressure ≥ 130/85 mmhg (or treated for hypertension)* fasting plasma glucose ≥ 6.1 mmol/l (110 mg/dl)===american heart association===there is confusion as to whether, in 2004, the aha/nhlbi intended to create another set of guidelines or simply update the ncep atp iii definition.